What behavioral side effects can lamotrigine, brivaracetam, and sodium valproate (valproic acid) cause in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Behavioral Side Effects of Lamotrigine, Brivaracetam, and Sodium Valproate in Children

Sodium valproate causes the most significant behavioral problems in children, including attention problems, hyperactivity, and externalizing behaviors, and should be avoided when alternatives exist. Lamotrigine causes primarily tics and insomnia, while brivaracetam is associated with irritability and behavioral changes.

Sodium Valproate (Valproic Acid)

Valproate consistently demonstrates the worst behavioral profile among these three medications in pediatric populations. The evidence is particularly strong:

  • In children with childhood absence epilepsy, valproate produced significantly higher attention problems (score 57.8 vs 54.6 for ethosuximide), total behavioral problems (51.7 vs 46.5), externalizing problems (51.4 vs 45.8), and attention-deficit/hyperactivity problems (55.8 vs 53.0) at 16-20 weeks compared to other antiepileptic drugs 1

  • These attention problems persisted at 12 months (score 57.9 vs 54.5), indicating this is not merely a transient effect 1

  • In a large study of 380 children with new-onset epilepsy, valproic acid demonstrated significantly greater behavioral side effects compared to all other antiepileptic drugs except levetiracetam 2

  • The FDA label explicitly lists emotional lability among the most common adverse reactions (>5%) 3

Critical Clinical Consideration

Children with baseline hyperactivity or impulsivity are at substantially higher risk for behavioral side effects with valproate. Baseline hyperactivity significantly predicted worse behavioral outcomes one month after starting any antiepileptic drug, but this effect was most pronounced with valproate 2. Screen for pre-existing attention problems before initiating valproate.

Lamotrigine

Lamotrigine has a more favorable behavioral profile but specific side effects occur:

  • Tics and insomnia are the primary nonserious behavioral adverse events, with tics occurring predominantly in children 4

  • Unusual but documented side effects include eye movement abnormalities, involuntary movements, and behavioral changes that resolve upon discontinuation 5

  • Importantly, lamotrigine has been associated with beneficial effects on cognition and behavior in some studies 6, distinguishing it from valproate

  • In prenatal exposure studies, lamotrigine-exposed children showed more attention deficit problems compared to levetiracetam-exposed children, but less anxious behavior 7

Rash Risk Amplification

The risk of serious rash (including Stevens-Johnson syndrome) is 3-fold higher in children (approximately 1%) than adults (0.3%) and is further increased by concomitant valproate use and rapid dose escalation 4, 6. Use slow titration protocols, especially when combined with valproate.

Brivaracetam

Brivaracetam has limited pediatric-specific data but available evidence indicates:

  • Irritability and behavioral changes are the primary behavioral side effects, though no serious behavioral adverse events are listed 4

  • In adult studies with various concomitant medications, brivaracetam was well-tolerated with drug-related adverse events ranging from 35.2-48.3% across different combinations 8

  • Brivaracetam is associated with decreased appetite in children, which may indirectly affect behavior 9

Age-Related Vulnerability

Younger children (ages 2-11 years) experience significantly greater behavioral side effects from antiepileptic drugs compared to adolescents (ages 12-18 years), regardless of which medication is used 2. Mean behavioral side effect scores were 25.08 in children versus 12.36 in adolescents. This developmental vulnerability should inform medication selection, with particular caution regarding valproate in younger age groups.

Clinical Decision Algorithm

  1. Screen for baseline hyperactivity/impulsivity before initiating any of these medications
  2. Avoid valproate in children when alternatives exist, particularly in:
    • Children with pre-existing attention problems
    • Younger children (under 12 years)
    • Girls of any age (due to teratogenicity concerns beyond behavioral effects)
  3. Choose lamotrigine when behavioral tolerability is a priority, using slow titration (especially with concomitant valproate)
  4. Consider brivaracetam as an alternative with a more neutral behavioral profile, though pediatric data are limited
  5. Monitor closely at 1 month after initiation, as behavioral side effects typically manifest early 2

Common Pitfall

Clinicians often fail to obtain baseline behavioral assessments before starting antiepileptic drugs. Without baseline data, it becomes impossible to distinguish drug-induced behavioral changes from pre-existing problems or disease progression. Use standardized tools like the Child Behavior Checklist before initiating therapy 2, 1.

Related Questions

Can antiepileptic drugs such as valproic acid, levetiracetam, lamotrigine, or lacosamide cause headache?
What is the recommended regimen for augmenting valproic acid with quetiapine (Seroquel) in a patient with psychosis?
What is the safest and most effective first‑line mood stabilizer for a pregnant woman with bipolar disorder?
Which of the following medications—quetiapine, duloxetine, lisinopril, gabapentin, Depakote (valproic acid), tramadol, indomethacin, and rizatriptan—can cause dry mouth?
A 74-year-old patient is yelling and screaming while taking quetiapine (Seroquel) 200 mg twice daily, valproic acid (Depakote) 250 mg twice daily, and lamotrigine (Lamictal) 100 mg twice daily; what should be done?
What is the appropriate next step in management for an 81‑year‑old man whose prostate‑specific antigen (PSA) is 4.94 ng/mL, up from 4.75 ng/mL two years ago?
What is the recommended evaluation and management for prominent breast ductules in a young pre‑menopausal woman who is asymptomatic?
How long do vesicles from herpes zoster (shingles) typically take to heal?
Which antiepileptic drugs, dosing protocols, and behavioral monitoring are recommended for autistic children with seizures, including avoidance of sodium valproate and use of lamotrigine or brivaracetam?
What are the recommended dosing guidelines for the albuterol HFA (90 µg per actuation) inhaler in adults and children?
In a patient with a right pelvic mass causing ureteral obstruction and hydronephrosis, which specialist should be referred to first?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.